Haoxi Health Technology Announces 1-for-128 Reverse Split, Par Value Rises to $0.32
Haoxi Health Technology will implement a 1-for-128 reverse share split, cutting Class A shares from 235,504,007 to about 1.84 million and Class B shares from 690,800 to roughly 5,397. Post-split par value rises to $0.32 and Class A shares trade on Nasdaq starting May 21, 2026.
1. Reverse Share Split Details
In March 2026, Haoxi Health Technology’s board approved a 1-for-128 reverse share split for both Class A and Class B ordinary shares. The split takes effect at the Nasdaq open on May 21, 2026, raising par value per share from $0.0025 to $0.32 and assigning a new CUSIP number G4290F126 for Class A shares.
2. Post-Split Capital Structure
The reverse split will reduce the number of issued and outstanding Class A shares from 235,504,007 to approximately 1,839,876 and Class B shares from 690,800 to about 5,397. All fractional share interests will be rounded up to the nearest whole share.
3. Shareholder Exchange Process
Transhare Corporation LLC is appointed as the exchange agent and paying agent, instructing shareholders on exchanging pre-split certificates for post-split shares or book-entry positions. Shareholders holding shares in brokerage accounts or in book-entry form are not required to take any action.
4. Company Profile
Haoxi Health Technology Limited is a Beijing-based provider of online marketing solutions for healthcare advertisers, specializing in short video campaigns on platforms such as Douyin, WeChat and Toutiao to improve customer acquisition efficiency.